Companies: 10,795·Total market cap: $144.5T
Calithera Biosciences, Inc.

Calithera Biosciences, Inc.

CALAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1462
P/E Ratio—
52W High$0.002
52W Low$0.0001
SEC Filings

Calithera Biosciences, Inc. (CALA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001496671 · CALA · OTC · as of Jun 8, 2026

Filing snapshot

530
Total Filings
CT ORDER
Latest Form
2023-06-15
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001496671 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-31
Fiscal Year End
Mar 31, 2023
Accession No.
0000950170-23-011047
Primary Document
cala-20221231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001496671 · Accession 0000950170-23-011047

Latest Key Filings

10-QQuarterly Report
10-Q
2022-11-14
View 10-Q on SEC
8-KCurrent Report
8-K
2023-01-25Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
CT ORDERCT ORDER
CT ORDER
2023-06-15
View
DEFM14ADEFM14A
DEFM14A
2023-06-05
View
PREM14APREM14A
PREM14A
2023-05-26
View
SC 13D/ASC 13D/A
SC 13D/A
2023-05-26
View
DEFA14AProxy Statement (Additional)
DEFA14A
2023-05-22
View
10-KAnnual Report
10-K
2023-03-31
View
EFFECTEFFECT
EFFECT
2023-03-17
View
15-12G15-12G
15-12G
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
S-8 POSS-8 POS
S-8 POS
2023-03-14
View
Showing 1–15 of 311 filingsForm 4 / 144 hidden· 530 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001496671  |  Exchange: OTC · Healthcare

Calithera Biosciences, Inc. (OTC: CALA) has submitted 530 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001496671, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Calithera Biosciences, Inc.'s most comprehensive regulatory disclosure. The most recent Calithera Biosciences, Inc. 10-K was filed on 2023-03-31 for fiscal year ending 2023. Historical CALA 10-K annual reports are available from 2010 through 2023.

Investors researching Calithera Biosciences, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ONPH SEC Filings →ARNI SEC Filings →BTTX SEC Filings →PANC SEC Filings →SCIE SEC Filings →IVBT SEC Filings →BXRXQ SEC Filings →KLDO SEC Filings →
→ CALA Financials→ CALA Earnings→ CALA Insider Trades

Frequently Asked Questions

CALA SEC Filings · 8 questions

Calithera Biosciences, Inc. (CALA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 530 filings and access original documents at no cost. Calithera Biosciences, Inc.'s CIK is 0001496671.

CALA SEC filingsCalithera Biosciences, Inc. SEC documentsfind CALA 10-K